亘喜生物并入阿斯利康将从纳斯达克退市

北京商报02-23

2月23日，亘喜生物科技集团宣布正式完成了此前公告的与阿斯利康集团的合并协议。合并完成后，亘喜生物不再是一家上市公司，而成为母公司的全资子公司。公司已要求纳斯达克向美国证券交易委员会（SEC）提交25表格，通知SEC本公司将从纳斯达克退市。（文章来源：北京商报）

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2413734046?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-23 17:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2413734046","market":"hk","top_or_hot":-1,"title":"亘喜生物并入阿斯利康 将从纳斯达克退市","media":"北京商报","content":"<div>\n<p>2月23日，亘喜生物科技集团宣布正式完成了此前公告的与阿斯利康集团的合并协议。合并完成后，亘喜生物不再是一家上市公司，而成为母公司的全资子公司。公司已要求纳斯达克向美国证券交易委员会（SEC）提交25表格，通知SEC本公司将从纳斯达克退市。（文章来源：北京商报）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202402232993093120.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亘喜生物并入阿斯利康 将从纳斯达克退市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亘喜生物并入阿斯利康 将从纳斯达克退市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-23 17:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202402232993093120.html><strong>北京商报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月23日，亘喜生物科技集团宣布正式完成了此前公告的与阿斯利康集团的合并协议。合并完成后，亘喜生物不再是一家上市公司，而成为母公司的全资子公司。公司已要求纳斯达克向美国证券交易委员会（SEC）提交25表格，通知SEC本公司将从纳斯达克退市。（文章来源：北京商报）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202402232993093120.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://finance.eastmoney.com/a/202402232993093120.html","article_id":"2413734046","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202402232993093120.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2413734046","pubTimestamp":1708679372,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"2月23日，亘喜生物科技集团宣布正式完成了此前公告的与阿斯利康集团的合并协议。合并完成后，亘喜生物不再是一家上市公司，而成为母公司的全资子公司。公司已要求纳斯达克向美国证券交易委员会（SEC）提交25表格，通知SEC本公司将从纳斯达克退市。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","BK1147":"投资银行业与经纪业","PSQ":"纳指反向ETF","03086":"华夏纳指","BK4139":"生物科技","QLD":"纳指两倍做多ETF","NDX":"纳斯达克100指数","BK4007":"制药","SQQQ":"纳指三倍做空ETF","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4535":"淡马锡持仓","GRCL":"亘喜生物","BK4568":"美国抗疫概念",".IXIC":"NASDAQ Composite","AZN":"阿斯利康","QQQ":"纳指100ETF","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","ARTL":"Artelo Biosciences, Inc.","QID":"纳指两倍做空ETF","TQQQ":"纳指三倍做多ETF","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD"},"translate_title":"Genxi Bio merged into AstraZeneca and will be delisted from Nasdaq","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03086":1,"NDX":1,"GRCL":1,".IXIC":1,"ARTL":1,"AZN":1,"TQQQ":0.6,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"NQmain":0.6,"MNQmain":0.6},"content_text":"2月23日，亘喜生物科技集团宣布正式完成了此前公告的与阿斯利康集团的合并协议。合并完成后，亘喜生物不再是一家上市公司，而成为母公司的全资子公司。公司已要求纳斯达克向美国证券交易委员会（SEC）提交25表格，通知SEC本公司将从纳斯达克退市。（文章来源：北京商报）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2413734046"}

亘喜生物并入阿斯利康 将从纳斯达克退市

精彩评论

亘喜生物并入阿斯利康将从纳斯达克退市